Recombinant tissue plasminogen activator (rt-PA) in fibrinolytic therapy

被引:1
|
作者
Werz, W [1 ]
Werner, RG [1 ]
机构
[1] Boehringer Ingelheim Pharma KG, Dept Biopharmaceut Manufacture, D-88397 Biberach, Germany
关键词
D O I
10.1016/S0168-1656(98)00022-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:157 / 158
页数:2
相关论文
共 50 条
  • [1] Difficulty in Applying Recombinant Tissue Plasminogen Activator (rt-PA)
    Sugimura, Yusuke
    Hoshino, Haruhiko
    INTERNAL MEDICINE, 2016, 55 (08) : 1027 - 1028
  • [2] Local recombinant tissue plasminogen activator (rt-PA) thrombolytic therapy in microvascular surgery
    Atiyeh, BS
    Hashim, HA
    Hamdan, AM
    Musharafieh, RS
    MICROSURGERY, 1999, 19 (06) : 265 - 271
  • [3] Thrombolysis with recombinant tissue plasminogen activator (rt-PA) in 13 children
    Schermer, E
    Streif, W
    Genser, N
    Frühwirth, M
    Trawöger, R
    Simma, B
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (21) : 927 - 933
  • [4] Intracoronary recombinant tissue-type plasminogen activator (rt-PA)
    Tiefenbrunn, AJ
    CORONARY ARTERY DISEASE, 1996, 7 (09) : 637 - 640
  • [5] Fibrinolytic treatment using recombinant tissue-type plasminogen activator (rt-PA) for staphylococcal infective endocarditis
    Takigawa, Tomoya
    Miyahara, Satoshi
    Ishii, Hiromu
    Ogawa, Midori
    Fukuda, Kazumasa
    Nishimura, Yosuke
    Saito, Mitsumasa
    MICROBIAL PATHOGENESIS, 2024, 197
  • [6] SYSTEMIC FIBRINOLYTIC EFFECTS OF TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) AND STREPTOKINASE (SK)
    OCKELFORD, PA
    SMITH, JM
    NORRIS, RM
    RIVERS, JT
    WHITE, HD
    ARTERIOSCLEROSIS, 1988, 8 (05): : A704 - A704
  • [7] Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood
    Serpi, M
    Schmidt, KG
    Kreuz, W
    Bucsenez, D
    Springer, W
    Hagl, S
    Ulmer, HE
    ZEITSCHRIFT FUR KARDIOLOGIE, 2001, 90 (03): : 191 - +
  • [8] The rehabilitation outcomes of stroke patients receiving recombinant tissue plasminogen activator (rt-PA)
    Foley, NC
    Teasell, RW
    Bhogal, SK
    Salter, KL
    STROKE, 2004, 35 (06) : E311 - E311
  • [9] Effect size of treatment with recombinant tissue plasminogen activator (rt-PA) on death and dependency
    Bhogal, SK
    Teasell, RW
    Foley, NC
    Speechley, MR
    STROKE, 2004, 35 (06) : E215 - E215
  • [10] Investigation of intravenous recombinant tissue plasminogen activator(rt-PA) therapy and endovascular therapy at Aichi Medical University Hospital
    Ando, H.
    Niwa, J.
    Ooiwa, H.
    Nakagawa, M.
    Nagatomi, C.
    Saeki, S.
    Yasumoto, A.
    Yuasa, T.
    Taguchi, S.
    Higa, T.
    Fjikake, A.
    Fukuoka, T.
    Tokui, K.
    Okada, Y.
    Masayuki, I.
    Nakao, N.
    Doyu, M.
    Matsuo, N.
    Sigeru, M.
    Takayasu, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 394 - 394